InvestorsHub Logo
Followers 88
Posts 1174
Boards Moderated 0
Alias Born 09/10/2017

Re: flipper44 post# 307611

Tuesday, 09/15/2020 8:38:18 PM

Tuesday, September 15, 2020 8:38:18 PM

Post# of 703870
Right flip, that’s exactly what Gilead wisely decided to do with their Kite acquisition:

Kite gets freedom to fly after separation from Gilead
08-May-2019 By Vassia Barba

Gilead’s new CEO unties Kite as an independent business unit to give Yescarta’s manufacturer more autonomy in the biotech sky. During a first-quarter earnings conference call, Daniel O’Day, former Roche Pharmaceuticals CEO who took Gilead’s helm in March, announced the plan to separate Kite Pharma, which Gilead acquired in 2017 for $11,9bn . . .

https://www.biopharma-reporter.com/Article/2019/05/08/Gilead-separates-Kite-Pharma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News